{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:46:33Z","timestamp":1789177593213,"version":"build-2803163510"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM067260"],"award-info":[{"award-number":["GM067260"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM135158"],"award-info":[{"award-number":["GM135158"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["5T32DK007201-43"],"award-info":[{"award-number":["5T32DK007201-43"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL036153."],"award-info":[{"award-number":["HL036153."]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s00018-023-05026-w","type":"journal-article","created":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T07:02:25Z","timestamp":1701068545000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Molecular modeling of apoE in complexes with Alzheimer\u2019s amyloid-\u03b2 fibrils from human brain suggests a structural basis for apolipoprotein co-deposition with amyloids"],"prefix":"10.1007","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9551-536X","authenticated-orcid":false,"given":"Emily","family":"Lewkowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari N.","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4717-5700","authenticated-orcid":false,"given":"Michael J.","family":"Rynkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8598-4824","authenticated-orcid":false,"given":"Olga","family":"Gursky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,27]]},"reference":[{"key":"5026_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/13506129.2022.2147636","volume":"29","author":"JN Buxbaum","year":"2022","unstructured":"Buxbaum JN, Dispenzieri A, Eisenberg DS, F\u00e4ndrich M, Merlini G, Saraiva MJM, Sekijima Y, Westermark P (2022) Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee. Amyloid 29:213\u2013219. https:\/\/doi.org\/10.1080\/13506129.2022.2147636","journal-title":"Amyloid"},{"key":"5026_CR2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","volume":"71","author":"GS Bloom","year":"2014","unstructured":"Bloom GS (2014) Amyloid-\u03b2 and Tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol 71:505. https:\/\/doi.org\/10.1001\/jamaneurol.2013.5847","journal-title":"JAMA Neurol"},{"key":"5026_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.neuron.2020.10.008","volume":"109","author":"Y Chen","year":"2021","unstructured":"Chen Y, Strickland MR, Soranno A, Holtzman DM (2021) Apolipoprotein E: structural insights and links to Alzheimer disease pathogenesis. Neuron 109:205\u2013221. https:\/\/doi.org\/10.1016\/j.neuron.2020.10.008","journal-title":"Neuron"},{"key":"5026_CR4","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.neuron.2022.03.004","volume":"110","author":"YA Martens","year":"2022","unstructured":"Martens YA, Zhao N, Liu C-C, Kanekiyo T, Yang AJ, Goate AM, Holtzman DM, Bu G (2022) ApoE cascade hypothesis in the pathogenesis of Alzheimer\u2019s disease and related dementias. Neuron 110:1304\u20131317. https:\/\/doi.org\/10.1016\/j.neuron.2022.03.004","journal-title":"Neuron"},{"key":"5026_CR5","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1093\/brain\/awad005","volume":"146","author":"R Perneczky","year":"2023","unstructured":"Perneczky R, Jessen F, Grimmer T, Levin J, Fl\u00f6el A, Peters O, Froelich L (2023) Anti-amyloid antibody therapies in Alzheimer\u2019s disease. Brain 146:842\u2013849. https:\/\/doi.org\/10.1093\/brain\/awad005","journal-title":"Brain"},{"key":"5026_CR6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s12551-017-0271-9","volume":"9","author":"KL Stewart","year":"2017","unstructured":"Stewart KL, Radford SE (2017) Amyloid plaques beyond A\u03b2: a survey of the diverse modulators of amyloid aggregation. Biophys Rev 9:405\u2013419. https:\/\/doi.org\/10.1007\/s12551-017-0271-9","journal-title":"Biophys Rev"},{"key":"5026_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/13506129.2022.2120800","volume":"30","author":"Y Misumi","year":"2023","unstructured":"Misumi Y, Tabata Y, Tasaki M, Obayashi K, Yamakawa S, Nomura T, Ueda M (2023) Binding of serum-derived amyloid-associated proteins to amyloid fibrils. Amyloid 30:67\u201373. https:\/\/doi.org\/10.1080\/13506129.2022.2120800","journal-title":"Amyloid"},{"key":"5026_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104784","volume":"138","author":"T Wisniewski","year":"2020","unstructured":"Wisniewski T, Drummond E (2020) APOE-amyloid interaction: therapeutic targets. Neurobiol Dis 138:104784. https:\/\/doi.org\/10.1016\/j.nbd.2020.104784","journal-title":"Neurobiol Dis"},{"key":"5026_CR9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2206240119","volume":"119","author":"KA Murray","year":"2022","unstructured":"Murray KA, Hu CJ, Griner SL, Pan H, Bowler JT, Abskharon R, Rosenberg GM, Cheng X, Seidler PM, Eisenberg DS (2022) De novo designed protein inhibitors of amyloid aggregation and seeding. Proc Natl Acad Sci 119:e2206240119. https:\/\/doi.org\/10.1073\/pnas.2206240119","journal-title":"Proc Natl Acad Sci"},{"key":"5026_CR10","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41580-018-0060-8","volume":"19","author":"MG Iadanza","year":"2018","unstructured":"Iadanza MG, Jackson MP, Hewitt EW, Ranson NA, Radford SE (2018) A new era for understanding amyloid structures and disease. Nat Rev Mol Cell Biol 19:755\u2013773. https:\/\/doi.org\/10.1038\/s41580-018-0060-8","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5026_CR11","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.1016\/j.cell.2021.08.013","volume":"184","author":"MR Sawaya","year":"2021","unstructured":"Sawaya MR, Hughes MP, Rodriguez JA, Riek R, Eisenberg DS (2021) The expanding amyloid family: Structure, stability, function, and pathogenesis. Cell 184:4857\u20134873. https:\/\/doi.org\/10.1016\/j.cell.2021.08.013","journal-title":"Cell"},{"key":"5026_CR12","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.tibs.2021.05.003","volume":"46","author":"E Lewkowicz","year":"2021","unstructured":"Lewkowicz E, Jayaraman S, Gursky O (2021) Protein amyloid cofactors: charged side-chain arrays meet their match? Trends Biochem Sci 46:626\u2013629. https:\/\/doi.org\/10.1016\/j.tibs.2021.05.003","journal-title":"Trends Biochem Sci"},{"key":"5026_CR13","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.1038\/s41467-022-31790-7","volume":"13","author":"Y Tao","year":"2022","unstructured":"Tao Y, Sun Y, Lv S, Xia W, Zhao K, Xu Q, Zhao Q, He L, Le W, Wang Y, Liu C, Li D (2022) Heparin induces \u03b1-synuclein to form new fibril polymorphs with attenuated neuropathology. Nat Commun 13:4226. https:\/\/doi.org\/10.1038\/s41467-022-31790-7","journal-title":"Nat Commun"},{"key":"5026_CR14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2119952119","volume":"119","author":"R Abskharon","year":"2022","unstructured":"Abskharon R, Sawaya MR, Boyer DR, Cao Q, Nguyen BA, Cascio D, Eisenberg DS (2022) Cryo-EM structure of RNA-induced tau fibrils reveals a small C-terminal core that may nucleate fibril formation. Proc Natl Acad Sci 119:e2119952119. https:\/\/doi.org\/10.1073\/pnas.2119952119","journal-title":"Proc Natl Acad Sci"},{"key":"5026_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1126\/science.abm7285","volume":"375","author":"Y Yang","year":"2022","unstructured":"Yang Y, Arseni D, Zhang W, Huang M, L\u00f6vestam S, Schweighauser M, Kotecha A, Murzin AG, Peak-Chew SY, Macdonald J, Lavenir I, Garringer HJ, Gelpi E, Newell KL, Kovacs GG, Vidal R, Ghetti B, Ryskeldi-Falcon B, Scheres SHW, Goedert M (2022) Cryo-EM structures of amyloid-\u03b2 42 filaments from human brains. Science 375:167\u2013172. https:\/\/doi.org\/10.1126\/science.abm7285","journal-title":"Science"},{"key":"5026_CR16","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41594-020-00515-z","volume":"27","author":"C Seuring","year":"2020","unstructured":"Seuring C, Verasdonck J, Gath J, Ghosh D, Nespovitaya N, W\u00e4lti MA, Maji SK, Cadalbert R, G\u00fcntert P, Meier BH, Riek R (2020) The three-dimensional structure of human \u03b2-endorphin amyloid fibrils. Nat Struct Mol Biol 27:1178\u20131184. https:\/\/doi.org\/10.1038\/s41594-020-00515-z","journal-title":"Nat Struct Mol Biol"},{"key":"5026_CR17","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nri1372","volume":"4","author":"S-Y Seong","year":"2004","unstructured":"Seong S-Y, Matzinger P (2004) Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol 4:469\u2013478. https:\/\/doi.org\/10.1038\/nri1372","journal-title":"Nat Rev Immunol"},{"key":"5026_CR18","doi-asserted-by":"publisher","first-page":"6810","DOI":"10.1038\/s41467-022-34552-7","volume":"13","author":"B Frieg","year":"2022","unstructured":"Frieg B, Antonschmidt L, Dienemann C, Geraets JA, Najbauer EE, Matthes D, de Groot BL, Andreas LB, Becker S, Griesinger C, Schr\u00f6der GF (2022) The 3D structure of lipidic fibrils of \u03b1-synuclein. Nat Commun 13:6810. https:\/\/doi.org\/10.1038\/s41467-022-34552-7","journal-title":"Nat Commun"},{"key":"5026_CR19","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/iub.1314","volume":"66","author":"MC Phillips","year":"2014","unstructured":"Phillips MC (2014) Apolipoprotein E isoforms and lipoprotein metabolism: apolipoprotein E isoforms and lipoprotein metabolism. IUBMB Life 66:616\u2013623. https:\/\/doi.org\/10.1002\/iub.1314","journal-title":"IUBMB Life"},{"key":"5026_CR20","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00109-016-1427-y","volume":"94","author":"RW Mahley","year":"2016","unstructured":"Mahley RW (2016) Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders. J Mol Med 94:739\u2013746. https:\/\/doi.org\/10.1007\/s00109-016-1427-y","journal-title":"J Mol Med"},{"key":"5026_CR21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1220484110","author":"PB Verghese","year":"2013","unstructured":"Verghese PB, Castellano JM, Garai K, Wang Y, Jiang H, Shah A, Bu G, Frieden C, Holtzman DM (2013) ApoE influences amyloid-\u03b2 (A\u03b2) clearance despite minimal apoE\/A\u03b2 association in physiological conditions. Proc Natl Acad Sci. https:\/\/doi.org\/10.1073\/pnas.1220484110","journal-title":"Proc Natl Acad Sci"},{"key":"5026_CR22","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","volume":"81","author":"T Kanekiyo","year":"2014","unstructured":"Kanekiyo T, Xu H, Bu G (2014) ApoE and A\u03b2 in Alzheimer\u2019s disease: accidental encounters or partners? Neuron 81:740\u2013754. https:\/\/doi.org\/10.1016\/j.neuron.2014.01.045","journal-title":"Neuron"},{"key":"5026_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jalz.2017.05.006","volume":"14","author":"KL Rasmussen","year":"2018","unstructured":"Rasmussen KL, Tybj\u00e6rg-Hansen A, Nordestgaard BG, Frikke-Schmidt R (2018) Plasma apolipoprotein E levels and risk of dementia: a Mendelian randomization study of 106,562 individuals. Alzheimers Dement 14:71\u201380. https:\/\/doi.org\/10.1016\/j.jalz.2017.05.006","journal-title":"Alzheimers Dement"},{"key":"5026_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0022-2275(20)41536-6","volume":"33","author":"J Segrest","year":"1992","unstructured":"Segrest J, Jones M, De Loof H, Brouillette C, Venkatachalapathi Y, Anantharamaiah G (1992) The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. J Lipid Res 33:141\u2013166. https:\/\/doi.org\/10.1016\/S0022-2275(20)41536-6","journal-title":"J Lipid Res"},{"key":"5026_CR25","doi-asserted-by":"publisher","first-page":"50380","DOI":"10.1074\/jbc.M204898200","volume":"277","author":"JA Morrow","year":"2002","unstructured":"Morrow JA, Hatters DM, Lu B, H\u00f6chtl P, Oberg KA, Rupp B, Weisgraber KH (2002) Apolipoprotein E4 forms a molten globule. J Biol Chem 277:50380\u201350385. https:\/\/doi.org\/10.1074\/jbc.M204898200","journal-title":"J Biol Chem"},{"key":"5026_CR26","doi-asserted-by":"publisher","first-page":"14273","DOI":"10.1074\/jbc.M313318200","volume":"279","author":"V Narayanaswami","year":"2004","unstructured":"Narayanaswami V, Maiorano JN, Dhanasekaran P, Ryan RO, Phillips MC, Lund-Katz S, Davidson WS (2004) Helix orientation of the functional domains in apolipoprotein e in discoidal high density lipoprotein particles. J Biol Chem 279:14273\u201314279. https:\/\/doi.org\/10.1074\/jbc.M313318200","journal-title":"J Biol Chem"},{"key":"5026_CR27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jmb.2008.12.040","volume":"386","author":"DM Hatters","year":"2009","unstructured":"Hatters DM, Voss JC, Budamagunta MS, Newhouse YN, Weisgraber KH (2009) Insight on the molecular envelope of lipid-bound apolipoprotein E from electron paramagnetic resonance spectroscopy. J Mol Biol 386:261\u2013271. https:\/\/doi.org\/10.1016\/j.jmb.2008.12.040","journal-title":"J Mol Biol"},{"key":"5026_CR28","doi-asserted-by":"publisher","first-page":"14813","DOI":"10.1073\/pnas.1106420108","volume":"108","author":"J Chen","year":"2011","unstructured":"Chen J, Li Q, Wang J (2011) Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions. Proc Natl Acad Sci 108:14813\u201314818. https:\/\/doi.org\/10.1073\/pnas.1106420108","journal-title":"Proc Natl Acad Sci"},{"key":"5026_CR29","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1126\/science.2063194","volume":"252","author":"C Wilson","year":"1991","unstructured":"Wilson C, Wardell MR, Weisgraber KH, Mahley RW, Agard DA (1991) Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. Science 252:1817\u20131822. https:\/\/doi.org\/10.1126\/science.2063194","journal-title":"Science"},{"key":"5026_CR30","doi-asserted-by":"publisher","first-page":"6292","DOI":"10.1073\/pnas.1705080114","volume":"114","author":"C Frieden","year":"2017","unstructured":"Frieden C, Wang H, Ho CMW (2017) A mechanism for lipid binding to apoE and the role of intrinsically disordered regions coupled to domain\u2013domain interactions. Proc Natl Acad Sci 114:6292\u20136297. https:\/\/doi.org\/10.1073\/pnas.1705080114","journal-title":"Proc Natl Acad Sci"},{"key":"5026_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1006165","volume":"14","author":"N Henry","year":"2018","unstructured":"Henry N, Krammer E-M, Stengel F, Adams Q, Van Liefferinge F, Hubin E, Chaves R, Efremov R, Aebersold R, Vandenbussche G, Pr\u00e9vost M, Raussens V, Deroo S (2018) Lipidated apolipoprotein E4 structure and its receptor binding mechanism determined by a combined cross-linking coupled to mass spectrometry and molecular dynamics approach. PLOS Comput Biol 14:e1006165. https:\/\/doi.org\/10.1371\/journal.pcbi.1006165","journal-title":"PLOS Comput Biol"},{"key":"5026_CR32","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1172\/JCI117407","volume":"94","author":"DA Sanan","year":"1994","unstructured":"Sanan DA, Weisgraber KH, Russell SJ, Mahley RW, Huang D, Saunders A, Schmechel D, Wisniewski T, Frangione B, Roses AD (1994) Apolipoprotein E associates with beta amyloid peptide of Alzheimer\u2019s disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. J Clin Invest 94:860\u2013869. https:\/\/doi.org\/10.1172\/JCI117407","journal-title":"J Clin Invest"},{"key":"5026_CR33","doi-asserted-by":"publisher","first-page":"10602","DOI":"10.1074\/jbc.271.18.10602","volume":"271","author":"AA Golabek","year":"1996","unstructured":"Golabek AA, Soto C, Vogel T, Wisniewski T (1996) The interaction between apolipoprotein E and Alzheimer\u2019s amyloid \u03b2-peptide is dependent on \u03b2-peptide conformation. J Biol Chem 271:10602\u201310606. https:\/\/doi.org\/10.1074\/jbc.271.18.10602","journal-title":"J Biol Chem"},{"key":"5026_CR34","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1021\/cb500994j","volume":"10","author":"S Deroo","year":"2015","unstructured":"Deroo S, Stengel F, Mohammadi A, Henry N, Hubin E, Krammer E-M, Aebersold R, Raussens V (2015) Chemical cross-linking\/mass spectrometry maps the amyloid \u03b2 peptide binding region on both apolipoprotein E domains. ACS Chem Biol 10:1010\u20131016. https:\/\/doi.org\/10.1021\/cb500994j","journal-title":"ACS Chem Biol"},{"key":"5026_CR35","doi-asserted-by":"publisher","first-page":"4737","DOI":"10.1111\/febs.14988","volume":"286","author":"S Ghosh","year":"2019","unstructured":"Ghosh S, Sil TB, Dolai S, Garai K (2019) High-affinity multivalent interactions between apolipoprotein E and the oligomers of amyloid-\u03b2. FEBS J 286:4737\u20134753. https:\/\/doi.org\/10.1111\/febs.14988","journal-title":"FEBS J"},{"key":"5026_CR36","doi-asserted-by":"publisher","first-page":"35831","DOI":"10.1074\/jbc.M706425200","volume":"282","author":"MJ Gunzburg","year":"2007","unstructured":"Gunzburg MJ, Perugini MA, Howlett GJ (2007) Structural basis for the recognition and cross-linking of amyloid fibrils by human apolipoprotein E. J Biol Chem 282:35831\u201335841. https:\/\/doi.org\/10.1074\/jbc.M706425200","journal-title":"J Biol Chem"},{"key":"5026_CR37","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 261:921\u2013923. https:\/\/doi.org\/10.1126\/science.8346443","journal-title":"Science"},{"key":"5026_CR38","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci 90:1977\u20131981. https:\/\/doi.org\/10.1073\/pnas.90.5.1977","journal-title":"Proc Natl Acad Sci"},{"key":"5026_CR39","doi-asserted-by":"publisher","first-page":"11657","DOI":"10.1021\/bi000099m","volume":"39","author":"JA Morrow","year":"2000","unstructured":"Morrow JA, Segall ML, Lund-Katz S, Phillips MC, Knapp M, Rupp B, Weisgraber KH (2000) Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain. Biochemistry 39:11657\u201311666. https:\/\/doi.org\/10.1021\/bi000099m","journal-title":"Biochemistry"},{"key":"5026_CR40","doi-asserted-by":"publisher","first-page":"30654","DOI":"10.1038\/srep30654","volume":"6","author":"I Dafnis","year":"2016","unstructured":"Dafnis I, Argyri L, Sagnou M, Tzinia A, Tsilibary EC, Stratikos E, Chroni A (2016) The ability of apolipoprotein E fragments to promote intraneuronal accumulation of amyloid beta peptide 42 is both isoform and size-specific. Sci Rep 6:30654. https:\/\/doi.org\/10.1038\/srep30654","journal-title":"Sci Rep"},{"key":"5026_CR41","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1038\/s41598-019-40438-4","volume":"9","author":"A Mouchard","year":"2019","unstructured":"Mouchard A, Boutonnet M-C, Mazzocco C, Biendon N, Macrez N, Network N-C (2019) ApoE-fragment\/A\u03b2 heteromers in the brain of patients with Alzheimer\u2019s disease. Sci Rep 9:3989. https:\/\/doi.org\/10.1038\/s41598-019-40438-4","journal-title":"Sci Rep"},{"key":"5026_CR42","doi-asserted-by":"publisher","first-page":"204062232210816","DOI":"10.1177\/20406223221081605","volume":"13","author":"FL Vecchio","year":"2022","unstructured":"Vecchio FL, Bisceglia P, Imbimbo BP, Lozupone M, Latino RR, Resta E, Leone M, Solfrizzi V, Greco A, Daniele A, Watling M, Panza F, Seripa D (2022) Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer\u2019s disease? Ther Adv Chronic Dis 13:204062232210816. https:\/\/doi.org\/10.1177\/20406223221081605","journal-title":"Ther Adv Chronic Dis"},{"key":"5026_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105631","volume":"164","author":"H-J Moon","year":"2022","unstructured":"Moon H-J, Haroutunian V, Zhao L (2022) Human apolipoprotein E isoforms are differentially sialylated and the sialic acid moiety in ApoE2 attenuates ApoE2-A\u03b2 interaction and A\u03b2 fibrillation. Neurobiol Dis 164:105631. https:\/\/doi.org\/10.1016\/j.nbd.2022.105631","journal-title":"Neurobiol Dis"},{"key":"5026_CR44","doi-asserted-by":"publisher","first-page":"6336","DOI":"10.3390\/ijms21176336","volume":"21","author":"MF Lanfranco","year":"2020","unstructured":"Lanfranco MF, Ng CA, Rebeck GW (2020) ApoE lipidation as a therapeutic target in Alzheimer\u2019s disease. Int J Mol Sci 21:6336. https:\/\/doi.org\/10.3390\/ijms21176336","journal-title":"Int J Mol Sci"},{"key":"5026_CR45","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41586-022-05439-w","volume":"611","author":"JW Blanchard","year":"2022","unstructured":"Blanchard JW, Akay LA, Davila-Velderrain J, von Maydell D, Mathys H, Davidson SM, Effenberger A, Chen C-Y, Maner-Smith K, Hajjar I, Ortlund EA, Bula M, Agbas E, Ng A, Jiang X, Kahn M, Blanco-Duque C, Lavoie N, Liu L, Reyes R, Lin Y-T, Ko T, R\u2019Bibo L, Ralvenius WT, Bennett DA, Cam HP, Kellis M, Tsai L-H (2022) APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes. Nature 611:769\u2013779. https:\/\/doi.org\/10.1038\/s41586-022-05439-w","journal-title":"Nature"},{"key":"5026_CR46","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/0896-6273(93)90070-8","volume":"11","author":"G William Rebeck","year":"1993","unstructured":"William Rebeck G, Reiter JS, Strickland DK, Hyman BT (1993) Apolipoprotein E in sporadic Alzheimer\u2019s disease: allelic variation and receptor interactions. Neuron 11:575\u2013580. https:\/\/doi.org\/10.1016\/0896-6273(93)90070-8","journal-title":"Neuron"},{"key":"5026_CR47","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/0-387-23226-5_13","volume-title":"Alzheimer\u2019s Disease","author":"DB Carter","year":"2005","unstructured":"Carter DB (2005) The Interaction of Amyloid-\u03b2 with ApoE: The form of beta amyloid is a partial determinant of the interaction with Apolipoprotein E. In: Harris JR, Fahrenholz F (eds) Alzheimer\u2019s Disease. Springer, Boston, pp 255\u2013272"},{"key":"5026_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2019.134285","volume":"707","author":"D Balu","year":"2019","unstructured":"Balu D, Karstens AJ, Loukenas E, Maldonado Weng J, York JM, Valencia-Olvera AC, LaDu MJ (2019) The role of APOE in transgenic mouse models of AD. Neurosci Lett 707:134285. https:\/\/doi.org\/10.1016\/j.neulet.2019.134285","journal-title":"Neurosci Lett"},{"key":"5026_CR49","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1073\/pnas.050004797","volume":"97","author":"DM Holtzman","year":"2000","unstructured":"Holtzman DM, Bales KR, Tenkova T, Fagan AM, Parsadanian M, Sartorius LJ, Mackey B, Olney J, McKeel D, Wozniak D, Paul SM (2000) Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci 97:2892\u20132897. https:\/\/doi.org\/10.1073\/pnas.050004797","journal-title":"Proc Natl Acad Sci"},{"key":"5026_CR50","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.neuron.2017.11.013","volume":"96","author":"C-C Liu","year":"2017","unstructured":"Liu C-C, Zhao N, Fu Y, Wang N, Linares C, Tsai C-W, Bu G (2017) ApoE4 accelerates early seeding of amyloid pathologY. Neuron 96:1024-1032.e3. https:\/\/doi.org\/10.1016\/j.neuron.2017.11.013","journal-title":"Neuron"},{"key":"5026_CR51","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1194\/jlr.R076315","volume":"58","author":"LM Tai","year":"2017","unstructured":"Tai LM, Balu D, Avila-Munoz E, Abdullah L, Thomas R, Collins N, Valencia-Olvera AC, LaDu MJ (2017) EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimer\u0149s disease. J Lipid Res 58:1733\u20131755. https:\/\/doi.org\/10.1194\/jlr.R076315","journal-title":"J Lipid Res"},{"key":"5026_CR52","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S1074-5521(96)90183-0","volume":"3","author":"SJ Wood","year":"1996","unstructured":"Wood SJ, Chan W, Wetzel R (1996) An ApoE-A\u03b2 inhibition complex in A\u03b2 fibril extension. Chem Biol 3:949\u2013956. https:\/\/doi.org\/10.1016\/S1074-5521(96)90183-0","journal-title":"Chem Biol"},{"key":"5026_CR53","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40478-019-0662-1","volume":"7","author":"Y Endo","year":"2019","unstructured":"Endo Y, Hasegawa K, Nomura R, Arishima H, Kikuta K, Yamashita T, Inoue Y, Ueda M, Ando Y, Wilson MR, Hamano T, Nakamoto Y, Naiki H (2019) Apolipoprotein E and clusterin inhibit the early phase of amyloid-\u03b2 aggregation in an in vitro model of cerebral amyloid angiopathy. Acta Neuropathol Commun 7:12. https:\/\/doi.org\/10.1186\/s40478-019-0662-1","journal-title":"Acta Neuropathol Commun"},{"key":"5026_CR54","doi-asserted-by":"publisher","first-page":"10571","DOI":"10.1021\/bi9626362","volume":"36","author":"S Aleshkov","year":"1997","unstructured":"Aleshkov S, Abraham CR, Zannis VI (1997) Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide \u03b2 (1\u201340). Relevance to Alzheimer\u2019s disease. Biochemistry 36:10571\u201310580. https:\/\/doi.org\/10.1021\/bi9626362","journal-title":"Biochemistry"},{"key":"5026_CR55","doi-asserted-by":"publisher","first-page":"6323","DOI":"10.1021\/bi5008172","volume":"53","author":"K Garai","year":"2014","unstructured":"Garai K, Verghese PB, Baban B, Holtzman DM, Frieden C (2014) The binding of apolipoprotein E to oligomers and fibrils of amyloid-\u03b2 alters the kinetics of amyloid aggregation. Biochemistry 53:6323\u20136331. https:\/\/doi.org\/10.1021\/bi5008172","journal-title":"Biochemistry"},{"key":"5026_CR56","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3390\/biom12030446","volume":"12","author":"AL Gharibyan","year":"2022","unstructured":"Gharibyan AL, Wasana Jayaweera S, Lehmann M, Anan I, Olofsson A (2022) Endogenous human proteins interfering with amyloid formation. Biomolecules 12:446. https:\/\/doi.org\/10.3390\/biom12030446","journal-title":"Biomolecules"},{"key":"5026_CR57","doi-asserted-by":"publisher","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance M, Schmechel D, Saunders AM, Goldgaber D, Roses AD (1993) Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci 90:8098\u20138102. https:\/\/doi.org\/10.1073\/pnas.90.17.8098","journal-title":"Proc Natl Acad Sci"},{"key":"5026_CR58","first-page":"1030","volume":"145","author":"T Wisniewski","year":"1994","unstructured":"Wisniewski T, Casta\u00f1o EM, Golabek A, Vogel T, Frangione B (1994) Acceleration of Alzheimer\u2019s fibril formation by apolipoprotein E in vitro. Am J Pathol 145:1030\u20131035","journal-title":"Am J Pathol"},{"key":"5026_CR59","doi-asserted-by":"publisher","first-page":"6243","DOI":"10.1021\/bi9624705","volume":"36","author":"H Naiki","year":"1997","unstructured":"Naiki H, Gejyo F, Nakakuki K (1997) Concentration-dependent inhibitory effects of apolipoprotein E on Alzheimer\u2019s \u03b2-amyloid fibril formation in Vitro. Biochemistry 36:6243\u20136250. https:\/\/doi.org\/10.1021\/bi9624705","journal-title":"Biochemistry"},{"key":"5026_CR60","doi-asserted-by":"publisher","first-page":"15163","DOI":"10.1074\/jbc.M114.622209","volume":"290","author":"Y Hori","year":"2015","unstructured":"Hori Y, Hashimoto T, Nomoto H, Hyman BT, Iwatsubo T (2015) Role of apolipoprotein E in \u03b2-amyloidogenesis. J Biol Chem 290:15163\u201315174. https:\/\/doi.org\/10.1074\/jbc.M114.622209","journal-title":"J Biol Chem"},{"key":"5026_CR61","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1073\/pnas.92.3.763","volume":"92","author":"KC Evans","year":"1995","unstructured":"Evans KC, Berger EP, Cho CG, Weisgraber KH, Lansbury PT (1995) Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease. Proc Natl Acad Sci 92:763\u2013767. https:\/\/doi.org\/10.1073\/pnas.92.3.763","journal-title":"Proc Natl Acad Sci"},{"key":"5026_CR62","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1111\/febs.15075","volume":"287","author":"T Islam","year":"2020","unstructured":"Islam T, Gharibyan AL, Golchin SA, Pettersson N, Br\u00e4nnstr\u00f6m K, Hedberg I, Virta M, Olofsson L, Olofsson A (2020) Apolipoprotein E impairs amyloid-\u03b2 fibril elongation and maturation. FEBS J 287:1208\u20131219. https:\/\/doi.org\/10.1111\/febs.15075","journal-title":"FEBS J"},{"key":"5026_CR63","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.jmb.2019.12.005","volume":"432","author":"BR Sahoo","year":"2020","unstructured":"Sahoo BR, Bekier ME, Liu Z, Kocman V, Stoddard AK, Anantharamaiah GM, Nowick J, Fierke CA, Wang Y, Ramamoorthy A (2020) Structural interaction of apolipoprotein A-I mimetic peptide with amyloid-\u03b2 generates toxic hetero-oligomers. J Mol Biol 432:1020\u20131034. https:\/\/doi.org\/10.1016\/j.jmb.2019.12.005","journal-title":"J Mol Biol"},{"key":"5026_CR64","doi-asserted-by":"publisher","first-page":"4760","DOI":"10.1038\/s41467-019-12683-8","volume":"10","author":"M Kollmer","year":"2019","unstructured":"Kollmer M, Close W, Funk L, Rasmussen J, Bsoul A, Schierhorn A, Schmidt M, Sigurdson CJ, Jucker M, F\u00e4ndrich M (2019) Cryo-EM structure and polymorphism of A\u03b2 amyloid fibrils purified from Alzheimer\u2019s brain tissue. Nat Commun 10:4760. https:\/\/doi.org\/10.1038\/s41467-019-12683-8","journal-title":"Nat Commun"},{"key":"5026_CR65","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.cell.2013.08.035","volume":"154","author":"J-X Lu","year":"2013","unstructured":"Lu J-X, Qiang W, Yau W-M, Schwieters CD, Meredith SC, Tycko R (2013) Molecular structure of \u03b2-amyloid fibrils in Alzheimer\u2019s disease brain tissue. Cell 154:1257\u20131268. https:\/\/doi.org\/10.1016\/j.cell.2013.08.035","journal-title":"Cell"},{"key":"5026_CR66","doi-asserted-by":"publisher","first-page":"17416","DOI":"10.1074\/jbc.M800756200","volume":"283","author":"CS Gangabadage","year":"2008","unstructured":"Gangabadage CS, Zdunek J, Tessari M, Nilsson S, Olivecrona G, Wijmenga SS (2008) Structure and dynamics of human apolipoprotein CIII. J Biol Chem 283:17416\u201317427. https:\/\/doi.org\/10.1074\/jbc.M800756200","journal-title":"J Biol Chem"},{"key":"5026_CR67","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3233\/JAD-140111","volume":"41","author":"Y-H Shih","year":"2014","unstructured":"Shih Y-H, Tsai K-J, Lee C-W, Shiesh S-C, Chen W-T, Pai M-C, Kuo Y-M (2014) Apolipoprotein C-III is an amyloid-\u03b2-binding protein and an early marker for Alzheimer\u2019s disease. J Alzheimers Dis 41:855\u2013865. https:\/\/doi.org\/10.3233\/JAD-140111","journal-title":"J Alzheimers Dis"},{"key":"5026_CR68","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3233\/JAD-181096","volume":"67","author":"Q Wang","year":"2019","unstructured":"Wang Q, Zhou W, Zhang J (2019) Higher apolipoprotein C-III levels in cerebrospinal fluid are associated with slower cognitive decline in mild cognitive impairment. J Alzheimers Dis 67:961\u2013969. https:\/\/doi.org\/10.3233\/JAD-181096","journal-title":"J Alzheimers Dis"},{"key":"5026_CR69","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/S0006-3495(92)81698-3","volume":"63","author":"RT Nolte","year":"1992","unstructured":"Nolte RT, Atkinson D (1992) Conformational analysis of apolipoprotein A-I and E-3 based on primary sequence and circular dichroism. Biophys J 63:1221\u20131239. https:\/\/doi.org\/10.1016\/S0006-3495(92)81698-3","journal-title":"Biophys J"},{"key":"5026_CR70","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nprot.2016.169","volume":"12","author":"D Kozakov","year":"2017","unstructured":"Kozakov D, Hall DR, Xia B, Porter KA, Padhorny D, Yueh C, Beglov D, Vajda S (2017) The ClusPro web server for protein\u2013protein docking. Nat Protoc 12:255\u2013278. https:\/\/doi.org\/10.1038\/nprot.2016.169","journal-title":"Nat Protoc"},{"key":"5026_CR71","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley P, Cowtan K (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60:2126\u20132132. https:\/\/doi.org\/10.1107\/S0907444904019158","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"5026_CR72","doi-asserted-by":"publisher","DOI":"10.1063\/5.0014475","volume":"153","author":"JC Phillips","year":"2020","unstructured":"Phillips JC, Hardy DJ, Maia JDC, Stone JE, Ribeiro JV, Bernardi RC, Buch R, Fiorin G, H\u00e9nin J, Jiang W, McGreevy R, Melo MCR, Radak BK, Skeel RD, Singharoy A, Wang Y, Roux B, Aksimentiev A, Luthey-Schulten Z, Kal\u00e9 LV, Schulten K, Chipot C, Tajkhorshid E (2020) Scalable molecular dynamics on CPU and GPU architectures with NAMD. J Chem Phys 153:044130. https:\/\/doi.org\/10.1063\/5.0014475","journal-title":"J Chem Phys"},{"key":"5026_CR73","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey W, Dalke A, Schulten K (1996) VMD: Visual molecular dynamics. J Mol Graph 14:33\u201338. https:\/\/doi.org\/10.1016\/0263-7855(96)00018-5","journal-title":"J Mol Graph"},{"key":"5026_CR74","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1711490115","author":"D Beglov","year":"2018","unstructured":"Beglov D, Hall DR, Wakefield AE, Luo L, Allen KN, Kozakov D, Whitty A, Vajda S (2018) Exploring the structural origins of cryptic sites on proteins. Proc Natl Acad Sci. https:\/\/doi.org\/10.1073\/pnas.1711490115","journal-title":"Proc Natl Acad Sci"},{"key":"5026_CR75","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.1021\/bi702097s","volume":"47","author":"S Tamamizu-Kato","year":"2008","unstructured":"Tamamizu-Kato S, Cohen JK, Drake CB, Kosaraju MG, Drury J, Narayanaswami V (2008) Interaction with amyloid \u03b2 peptide compromises the lipid binding function of apolipoprotein E. Biochemistry 47:5225\u20135234. https:\/\/doi.org\/10.1021\/bi702097s","journal-title":"Biochemistry"},{"key":"5026_CR76","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1074\/jbc.M510851200","volume":"281","author":"CA Peters-Libeu","year":"2006","unstructured":"Peters-Libeu CA, Newhouse Y, Hatters DM, Weisgraber KH (2006) Model of biologically active apolipoprotein E bound to dipalmitoylphosphatidylcholine. J Biol Chem 281:1073\u20131079. https:\/\/doi.org\/10.1074\/jbc.M510851200","journal-title":"J Biol Chem"},{"key":"5026_CR77","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1042\/bj3490077","volume":"349","author":"MH Baumann","year":"2000","unstructured":"Baumann MH, Kallij\u00e4rvi J, Lankinen H, Soto C, Haltia M (2000) Apolipoprotein E includes a binding site which is recognized by several amyloidogenic polypeptides. Biochem J 349:77\u201384. https:\/\/doi.org\/10.1042\/bj3490077","journal-title":"Biochem J"},{"key":"5026_CR78","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1073\/pnas.1114740109","volume":"109","author":"H Willander","year":"2012","unstructured":"Willander H, Askarieh G, Landreh M, Westermark P, Nordling K, Ker\u00e4nen H, Hermansson E, Hamvas A, Nogee LM, Bergman T, Saenz A, Casals C, \u00c5qvist J, J\u00f6rnvall H, Berglund H, Presto J, Knight SD, Johansson J (2012) High-resolution structure of a BRICHOS domain and its implications for anti-amyloid chaperone activity on lung surfactant protein C. Proc Natl Acad Sci 109:2325\u20132329. https:\/\/doi.org\/10.1073\/pnas.1114740109","journal-title":"Proc Natl Acad Sci"},{"key":"5026_CR79","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nsmb.2971","volume":"22","author":"SIA Cohen","year":"2015","unstructured":"Cohen SIA, Arosio P, Presto J, Kurudenkandy FR, Biverst\u00e5l H, Dolfe L, Dunning C, Yang X, Frohm B, Vendruscolo M, Johansson J, Dobson CM, Fisahn A, Knowles TPJ, Linse S (2015) A molecular chaperone breaks the catalytic cycle that generates toxic A\u03b2 oligomers. Nat Struct Mol Biol 22:207\u2013213. https:\/\/doi.org\/10.1038\/nsmb.2971","journal-title":"Nat Struct Mol Biol"},{"key":"5026_CR80","doi-asserted-by":"publisher","first-page":"11265","DOI":"10.1073\/pnas.1918481117","volume":"117","author":"M T\u00f6rnquist","year":"2020","unstructured":"T\u00f6rnquist M, Cukalevski R, Weininger U, Meisl G, Knowles TPJ, Leiding T, Malmendal A, Akke M, Linse S (2020) Ultrastructural evidence for self-replication of Alzheimer-associated A\u03b242 amyloid along the sides of fibrils. Proc Natl Acad Sci 117:11265\u201311273. https:\/\/doi.org\/10.1073\/pnas.1918481117","journal-title":"Proc Natl Acad Sci"},{"key":"5026_CR81","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/01.mol.0000169348.61191.ac","volume":"16","author":"O Gursky","year":"2005","unstructured":"Gursky O (2005) Apolipoprotein structure and dynamics. Curr Opin Lipidol 16:287\u2013294. https:\/\/doi.org\/10.1097\/01.mol.0000169348.61191.ac","journal-title":"Curr Opin Lipidol"},{"key":"5026_CR82","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S0022-2836(03)00520-5","volume":"329","author":"R Bussell","year":"2003","unstructured":"Bussell R, Eliezer D (2003) A structural and functional role for 11-mer repeats in \u03b1-Synuclein and other exchangeable lipid binding proteins. J Mol Biol 329:763\u2013778. https:\/\/doi.org\/10.1016\/S0022-2836(03)00520-5","journal-title":"J Mol Biol"},{"key":"5026_CR83","doi-asserted-by":"publisher","first-page":"1250494","DOI":"10.1126\/science.1250494","volume":"344","author":"T Saio","year":"2014","unstructured":"Saio T, Guan X, Rossi P, Economou A, Kalodimos CG (2014) Structural basis for protein antiaggregation activity of the trigger factor chaperone. Science 344:1250494. https:\/\/doi.org\/10.1126\/science.1250494","journal-title":"Science"},{"key":"5026_CR84","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13024-016-0099-y","volume":"11","author":"Y Fu","year":"2016","unstructured":"Fu Y, Zhao J, Atagi Y, Nielsen HM, Liu C-C, Zheng H, Shinohara M, Kanekiyo T, Bu G (2016) Apolipoprotein E lipoprotein particles inhibit amyloid-\u03b2 uptake through cell surface heparan sulphate proteoglycan. Mol Neurodegener 11:37. https:\/\/doi.org\/10.1186\/s13024-016-0099-y","journal-title":"Mol Neurodegener"},{"key":"5026_CR85","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1039\/c1cs15112f","volume":"41","author":"AS DeToma","year":"2012","unstructured":"DeToma AS, Salamekh S, Ramamoorthy A, Lim MH (2012) Misfolded proteins in Alzheimer\u2019s disease and type II diabetes. Chem Soc Rev 41:608\u2013621. https:\/\/doi.org\/10.1039\/c1cs15112f","journal-title":"Chem Soc Rev"},{"key":"5026_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105824","volume":"172","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Gao H, Zheng W, Xu H (2022) Current understanding of the interactions between metal ions and Apolipoprotein E in Alzheimer\u2019s disease. Neurobiol Dis 172:105824. https:\/\/doi.org\/10.1016\/j.nbd.2022.105824","journal-title":"Neurobiol Dis"},{"key":"5026_CR87","doi-asserted-by":"publisher","first-page":"7224","DOI":"10.1074\/jbc.RA120.012738","volume":"295","author":"C Wallin","year":"2020","unstructured":"Wallin C, Jarvet J, Biverst\u00e5l H, W\u00e4rml\u00e4nder S, Danielsson J, Gr\u00e4slund A, Abelein A (2020) Metal ion coordination delays amyloid-\u03b2 peptide self-assembly by forming an aggregation-inert complex. J Biol Chem 295:7224\u20137234. https:\/\/doi.org\/10.1074\/jbc.RA120.012738","journal-title":"J Biol Chem"},{"key":"5026_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2022.101594","volume":"59","author":"S Parhizkar","year":"2022","unstructured":"Parhizkar S, Holtzman DM (2022) APOE mediated neuroinflammation and neurodegeneration in Alzheimer\u2019s disease. Semin Immunol 59:101594. https:\/\/doi.org\/10.1016\/j.smim.2022.101594","journal-title":"Semin Immunol"},{"key":"5026_CR89","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1194\/jlr.R075481","volume":"58","author":"T-PV Huynh","year":"2017","unstructured":"Huynh T-PV, Davis AA, Ulrich JD, Holtzman DM (2017) Apolipoprotein E and Alzheimer\u2019s disease: the influence of apolipoprotein E on amyloid-\u03b2 and other amyloidogenic proteins. J Lipid Res 58:824\u2013836. https:\/\/doi.org\/10.1194\/jlr.R075481","journal-title":"J Lipid Res"},{"key":"5026_CR90","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.bpj.2013.05.004","volume":"105","author":"A Ramamoorthy","year":"2013","unstructured":"Ramamoorthy A, Lim MH (2013) Structural characterization and inhibition of toxic amyloid-\u03b2 oligomeric intermediates. Biophys J 105:287\u2013288. https:\/\/doi.org\/10.1016\/j.bpj.2013.05.004","journal-title":"Biophys J"},{"key":"5026_CR91","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1021\/acs.chemrev.0c01122","volume":"121","author":"PH Nguyen","year":"2021","unstructured":"Nguyen PH, Ramamoorthy A, Sahoo BR, Zheng J, Faller P, Straub JE, Dominguez L, Shea J-E, Dokholyan NV, De Simone A, Ma B, Nussinov R, Najafi S, Ngo ST, Loquet A, Chiricotto M, Ganguly P, McCarty J, Li MS, Hall C, Wang Y, Miller Y, Melchionna S, Habenstein B, Timr S, Chen J, Hnath B, Strodel B, Kayed R, Lesn\u00e9 S, Wei G, Sterpone F, Doig AJ, Derreumaux P (2021) Amyloid oligomers: a joint experimental\/computational perspective on Alzheimer\u2019s disease, Parkinson\u2019s disease, Type II diabetes, and amyotrophic lateral sclerosis. Chem Rev 121:2545\u20132647. https:\/\/doi.org\/10.1021\/acs.chemrev.0c01122","journal-title":"Chem Rev"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-023-05026-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-023-05026-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-023-05026-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T10:15:33Z","timestamp":1702980933000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-023-05026-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,27]]},"references-count":91,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["5026"],"URL":"https:\/\/doi.org\/10.1007\/s00018-023-05026-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.08.04.551703","asserted-by":"object"}]},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,27]]},"assertion":[{"value":"4 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no financial or any other conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable (there are no animals and no human subjects in this study).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors give their consent to publish this non-human subject study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"376"}}